Atormac
Neurology India
Open access journal indexed with Index Medicus
  Users online: 1024  
 Home | Login 
  About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Etcetera Contact  
  Navigate Here 
 Search
 
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (674 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article
   References
   Article Figures

 Article Access Statistics
    Viewed773    
    Printed15    
    Emailed0    
    PDF Downloaded21    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
LETTER TO EDITOR
Year : 2017  |  Volume : 65  |  Issue : 2  |  Page : 392-393

Neurological manifestation of Erdheim Chester disease: A series of 3 patients


1 Olive View-UCLA Medical Center, Sylmar, California; VA Greater Los Angeles HSC, Los Angeles, California, USA
2 Olive View-UCLA Medical Center, Sylmar, California; VA Greater Los Angeles HSC, Los Angeles, California; Keck School of Medicine, USC, Los Angeles, California; David Geffen School of Medicine, UCLA, Los Angeles, California, USA

Date of Web Publication10-Mar-2017

Correspondence Address:
Dr. Shrikant Mishra
16111 Plummer Street, North Hills, CA 91343, California
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/neuroindia.NI_1120_15

Rights and Permissions



How to cite this article:
Trikamji B, Mishra S. Neurological manifestation of Erdheim Chester disease: A series of 3 patients. Neurol India 2017;65:392-3

How to cite this URL:
Trikamji B, Mishra S. Neurological manifestation of Erdheim Chester disease: A series of 3 patients. Neurol India [serial online] 2017 [cited 2017 Nov 24];65:392-3. Available from: http://www.neurologyindia.com/text.asp?2017/65/2/392/201819


Sir,

First described in 1930 by Jacob Erdheim and William Chester,[1] Erdheim Chester disease (ECD) is a rare non-Langerhans-cell histiocytosis, which typically affects patients in their fifth decade, and more commonly affects men than women. Pathologically, the disease is characterized by infiltration of tissues by lipid-laden histiocytes. There is a predilection for the appendicular skeleton, particularly the long bones of the upper and lower extremities. The other common sites include the perinephric soft tissues, retroperitoneum, mediastinum, and pulmonary interstitium. The clinical course varies widely, depending on the extent of the disease, with some patients never developing symptoms and other patients succumbing after rapid disease progression. Neurologic involvement is encountered in fewer than 50% of patients with proven ECD, with the most common locations being the hypothalamic-pituitary axis, brain parenchyma, orbits, meninges, and paranasal sinuses. Less commonly affected areas include the spinal meninges and the bony spinal column.[2] Primary neurological disorders in ECD are less frequent and only a few patients with cerebellar symptoms such as dysarthria, nystagmus, cerebellar dysmetria and ataxia have been described in the recent literature.

We report three cases with ECD, with special reference to MRI and pathologic findings.

Our first case, a 63-year-old male patient presented with an one-year history of intermittent spasms lasting for approximately 20 seconds on the right side of his body involving his face, arm, and leg. The neurological examination was essentially normal and the cerebrospinal fluid (CSF) and electroencephalogram (EEG) were negative for infection and seizures. Magnetic resonance imaging (MRI) of the brain revealed contrast-enhancing infiltrating lesions in the pons, midbrain, and bilateral medial temporal lobes [Figure 1]a. Interestingly, computed tomographic (CT) scan of the thorax revealed nodular densities in the right and left middle lobes of the lung, without any evidence of hilar or axillary adenopathy. An extensive diagnostic work up including serum angiotensin converting enzyme level and lactate dehydrogenase, was negative except for the fact that the positron emission tomography (PET) study revealed that the lesion seen on MRI was intensely hypermetabolic. Two years later, he presented to the Neurology clinic with worsening diplopia and left-sided weakness, now requiring a cane to ambulate. On neurological exam, he was found to have diplopia, dysmetria, ataxia, and bilateral upgoing plantar reflex. Chest X-ray revealed opacities in the right and left lower lobes. The lung biopsies revealed nonspecific inflammation with aggregates of foamy histiocytes. Skeletal survey revealed femoral sclerosis, which was thought to be consistent with Erdheim Chester disease (EDC). The patient was treated with corticosteroids but continued to deteriorate in his clincal condition. He was recommended treatment with interferon and other immunosuppresants, which he denied.
Figure 1: (a) Case 1: Magnetic resonance imaging (MRI) of the brain revealed contrast-enhancing infiltrating lesions in the pons, midbrain, and bilateral medial temporal lobes (b) Case 2: (b): Extensive fluid-attenuated inversion recovery (FLAIR) hyperintense lesions in the belly of the pons, extending inferiorly to the upper medulla and laterally into the middle cerebellar peduncles (c) Case 3: MRI revealed bilateral mechanical ptosis secondary to a 15 mm × 8 mm elliptical lesion at the lateral aspect of righ upper eylid.

Click here to view


Our second case, a 29-year-old male patient presented with a 2-year history of gradually progressive episodes of headaches, difficulty in vision and speech, and a lack of balance and coordination. Neurological examination was significant due to the presence of disconjugate gaze, slurred speech, dysmetria on finger-to-nose and heel-to-shin tests, and an ataxic gait. Further investigation into various causes of ataxia revealed extensive fluid-attenuated inversion recovery (FLAIR) and T2-weighted hyperintense lesions in the belly of the pons, extending inferiorly to the upper medulla and laterally into the middle cerebellar peduncles [Figure 1]b. Bone scans revealed multiple lesions, and biopsy confirmed the diagnosis of EDC. The patient was started on a 36 week continuous chemotherapy with cladribine and showed an excellent response.

Our third case, a 45-year-old male patient presented with a 2-year history of gradually progressive bilateral orbital swelling and intermittent blurring of vision. Opthalmological examination and MRI revealed bilateral mechanical ptosis secondary to a 15 mm × 8 mm elliptical lesion at the lateral aspect of right upper eyelid [Figure 1]c. The lesion was found to be slightly mobile, soft, and fluctuant. The pupils were equal, round, reactive to light as well as the accommodation reflex, and extraocular movements were full and orthophoric. Visual acuity with correction was 20/25 bilaterally. Patient was prescribed steroids, which provided minimal relief. Surgical debulking of the lesion was performed subsequently, and pathological examination confirmed the diagnosis of ECD.

In ECD, skeletal lesions can be asymptomatic, and thus radiological identification of these lesions is extremely important for the diagnosis of this disease. MRI is of enormous value in diagnosing ECD. Gadolinium-enhanced MRI shows retention of enhancement even after several days. The prolonged retention may be due to the abnormal histiocytic content of the lesions.[3] When patients have central nervous system (CNS) involvement, they are often symptomatic, with diabetes insipidus and ataxia syndromes being the most common presentations.

ECD is a rare and potentially fatal entity that can involve any part of the body and has no known successful cure. It bears a striking resemblance to other histiocytic disorders. Although steroids and immunosuppresants have been tried in systemic ECD, CNS ECD has only shown minimal improvement with steroids and radiotherapy. Typical radiographic and pathological findings should alert the clinician to this potentially fatal disease.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Chester W. Uber lipoidgranulomatose. Virchows Arch A Pathol Anat Histol 1930;279:561-602.  Back to cited text no. 1
    
2.
Sedrak P, Ketonen L, Hou P, Guha-Thakurta N, Williams MD, Kurzrock R, et al. Erdheim-Chester disease of the central nervous system: New manifestations of a rare disease. AJNR Am J Neuroradiol 2011;32:2126-31.  Back to cited text no. 2
    
3.
Babu RP, Lansen TA, Chadburn A, Kasoff SS. Erdheim-Chester disease of the central nervous system. Report of two cases. J Neurosurg 1997;86:888-92.  Back to cited text no. 3
    


    Figures

  [Figure 1]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow